The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture-recapture analysis

Vaccine

Volumn 30, Issue 12, 2012, Pages 2168-2172

  Huang, Wan Ting ^a   Huang, Wei I ^b   Huang, Yu Wen ^c,d   Hsu, Chien Wen ^c   Chuang, Jen Hsiang ^a  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b Taiwan Drug Relief Foundation   (Taiwan)

^c Executive Yuan   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Pandemic influenza vaccine; Postmarketing surveillance; Spontaneous reporting; Taiwan; Vaccine safety

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ARTICLE; BELL PALSY; CHILD; CLINICAL ASSESSMENT; CONVULSION; DATA BASE; DRUG FATALITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; GUILLAIN BARRE SYNDROME; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; INFLUENZA VACCINATION; LICENSING; METHODOLOGY; MORTALITY; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; TAIWAN;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD, PRESCHOOL; DRUG TOXICITY; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; SURVIVAL ANALYSIS; TAIWAN; VACCINATION; YOUNG ADULT;

EID: 84862812070     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.01.013     Document Type: Article

References (34)

1. Huang W.T., Chen W.W., Yang H.W., Chen W.C., Chao Y.N., Huang Y.W., et al. Design of a robust infrastructure to monitor the safety of the pandemic A (H1N1) 2009 vaccination program in Taiwan. Vaccine 2010, 28:7161-7166.
2. Varricchio F., Iskander J., DeStefano F., Ball R., Pless R., Braun M.M., et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004, 23:287-294.
3. Rosenthal S., Chen R.T. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health 1995, 85:1706-1709.
4. Verstraeten T., Baughman A.L., Cadwell B., Zanardi L., Haber P., Chen R.T. Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination. Am J Epidemiol 2001, 154:1006-1012.
5. Carvajal A., Ortega P.G., Sáinz M., Velasco V., Salado I., Arias L.H., et al. Adverse events associated with pandemic influenza vaccines: comparison of the results of a follow-up study with those coming from spontaneous reporting. Vaccine 2011, 29:519-522.
6. Haber P., Patel M., Izurieta H.S., Baggs J., Gargiullo P., Weintraub E., et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006 to September 25, 2007. Pediatrics 2008, 121:1206-1212.
7. Hook E.B., Regal R.R. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev 1995, 17:243-264.
8. Capture-recapture and multiple-record systems estimation I: history and theoretical development. Am J Epidemiol 1995, 142:1047-1058. International Working Group for Disease Monitoring and Forecasting.
9. International Working Group for Disease Monitoring and Forecasting Capture-recapture and multiple-record systems estimation II: applications in human diseases. Am J Epidemiol 1995, 142:1059-1068.
10. Department of Health, Executive Yuan Pharmacovigilance in Taiwan. Available at [accessed August 31, 2011]. http://adr.doh.gov.tw/ADR-eng/index.htm.
11. European Medicines Agency CHMP recommendations for the pharmacovigilance plan as part of the risk management plan to be submitted with the marketing authorization application for a pandemic influenza vaccine. Available at [accessed August 31, 2011]. http://www.emea.eu/docs/en_GB/document_library/Report/2010/01/WC500051739.pdf.
12. Sejvar J.J., Kohl K.S., Gidudu J., Amato A., Bakshi N., Baxter R., et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011, 29:599-612.
13. Department of Health, Executive Yuan National Death Certification System [Chinese]. Available at [accessed August 31, 2011]. http://das.doh.gov.tw/DAS/.
14. Bureau of National Health Insurance. National Health Insurance in Taiwan; 2010. Available at [accessed August 31, 2011]. http://www.nhi.gov.tw/webdata/AttachFiles/Attach_13767_1_National%20Health%20Insurance%20in%20Taiwan%202010.pdf.
15. Chapman D.G. Some properties of the hypergeometric distribution with applications to zoological sample censuses 1951, University of California Publications in Statistics, Berkley, p. 131-160.
16. Seber G.A.F. The effect of trap response on tag recapture estimates. Biometrics 1970, 26:13-22.
17. Huang W.T., Chuang J.H., Kuo S.H. Monitoring the safety of pandemic H1N1 vaccine. Lancet 2010, 375:1164.
18. Office of Statistics Department of Health. Mortality Statistics; 2010 [Chinese]. Available at [accessed October 10, 2011]. http://www.doh.gov.tw/CHT2006/DM/DM2_2.aspx%3Fnow_fod_list_no=11962%26class_no=440%26level_no=4.
19. Weber J.C.P. Epidemiology of adverse reactions to non-steroidal anti-inflammatory drugs. Adv Inflamm Res 1984, 6:1-7.
20. Huang W.T. The Taiwan experience with pandemic (H1N1) 2009 vaccine safety monitoring. H1N1 vaccine safety monitoring: global lessons for a global pandemic; 27th international conference on pharmacoepidemiology & therapeutic risk management 2011, Available at https://www.pharmacoepi.org/meetings/27thconf/presentations/hot_topic_session.cfm [accessed October 10, 2011].
21. Schonberger L.B., Bregman D.J., Sullivan-Bolyai J.Z., Keenlyside R.A., Ziegler D.W., Retailliau H.F., et al. Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979, 110:105-123.
22. Lasky T., Terracciano G.J., Magder L., Koski C.L., Ballesteros M., Nash D., et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998, 339:1797-1802.
23. CDC Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. MMWR Morb Mortal Wkly Rep 2010, 59:657-661.
24. Dieleman J., Romio S., Johansen K., Weibel D., Bonhoeffer J., Sturkenboom M. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ 2011, 343:d3908.
25. Grimaldi-Bensouda L., Alperovitch A., Besson G., Vial C., Cuisset J.M., Papeix C., et al. Guillain-Barré syndrome, influenza-like illness, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol 2011, 174:326-335.
26. Andrews N., Stowe J., Salman R.A., Miller E. Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Vaccine 2011, 29:7878-7882.
27. Lee G.M., Greene S.K., Weintraub E.S., Baggs J., Kulldorff M., Fireman B.H., et al. H1N1 and seasonal influenza vaccine safety in the Vaccine Safety Datalink project. Am J Prev Med 2011, 41(2):121-128.
28. Silvers L.E., Ellenberg S.S., Wise R.P., Varricchio F.E., Mootrey G.T., Salive M.E. The epidemiology of fatalities reported to the Vaccine Adverse Event Reporting System 1990-1997. Pharmacoepidemiol Drug Saf 2001, 10:279-285.
29. Fine P.E.M., Chen R.T. Confounding in studies of adverse reactions to vaccines. Am J Epidemiol 1992, 136:121-135.
30. Fireman B., Lee J., Lewis N., Bembom O., van der Laan M., Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol 2009, 170:650-656.
31. Hook E.B., Regal R.R. Recommendations for presentation and evaluation of capture-recapture estimates in epidemiology. J Clin Epidemiol 1999, 52:917-926.
32. Zhou W., Pool V., DeStefano F., Iskander J.K., Haber P., Chen R.T. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. Pharmacoepidemiol Drug Saf 2004, 13:505-510.
33. Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004, 350:896-903.
34. Stowe J., Andrews N., Wise L., Miller E. Bell's palsy and parenteral inactivated influenza vaccine. Hum Vaccine 2006, 2(3):110-112.